OSR Holdings, Inc.OSR Holdings, Inc.OSR Holdings, Inc.

OSR Holdings, Inc.

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪12.73 M‬USD
−1.9996USD
‪−2.41 M‬USD
0.00USD
‪12.58 M‬
Beta (1Y)
1.03

About OSR Holdings, Inc.


CEO
Kuk-Hyoun Hwang
Headquarters
Bellevue
Founded
2020
Identifiers
3
ISIN US68840D1101
OSR Holdings, Inc. operates as a global healthcare company. The firm engages in developing oral immunotherapies for cancer treatment, design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention of medical devices and systems distribution in Korea. Its products are offered through its subsidiaries. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.